Current Issue
Immunogenicity / Biomarker
-
Human leukocyte antigens and haplotypes allow for prognostic classification of HNSCC patients
Immunogenicity / Biomarker, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810001 • DOI: 10.18416/CIO.2018.1810001
Views: 823 | Downloads: 376 -
Breaking the brake: targeting the immunosuppressive cells to optimize immunotherapy of cancer
Immunogenicity / Biomarker, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810002 • DOI: 10.18416/CIO.2018.1810002
Views: 729 | Downloads: 313 -
Immunotherapy and head and neck cancer: Focus on recurrent and metastatic disease
Immunogenicity / Biomarker, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810004 • DOI: 10.18416/CIO.2018.1810004
Views: 739 | Downloads: 336
Liquid Biopsy
-
Extracellular Vesicles as biomarkers for cancer progression and cancer associated VTE
Liquid Biopsy, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810005 • DOI: 10.18416/CIO.2018.1810005
Views: 768 | Downloads: 304 -
Immune modulation by extracellular vesicles released from mesenchymal cells
Liquid Biopsy, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810006 • DOI: 10.18416/CIO.2018.1810006
Views: 797 | Downloads: 353
Cellular Vaccines
-
CAR NK cells for cancer retargeting
Cellular Vaccines, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810009 • DOI: 10.18416/CIO.2018.1810009
Views: 1364 | Downloads: 412 -
Immune biological rationale for the design of radioimmunotherapies
Cellular Vaccines, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810010 • DOI: 10.18416/CIO.2018.1810010
Views: 716 | Downloads: 317 -
Role of resident memory T cells in cancer immunotherapy
Cellular Vaccines, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810011 • DOI: 10.18416/CIO.2018.1810011
Views: 746 | Downloads: 342 -
Perspectives of human gamma/delta T-cells in cancer immunotherapy
Cellular Vaccines, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810012 • DOI: 10.18416/CIO.2018.1810012
Views: 743 | Downloads: 298
New Targets
-
On the development of personalized cancer vaccines
New Targets, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810013 • DOI: 10.18416/CIO.2018.1810013
Views: 702 | Downloads: 301 -
Platelets regulate innate immunity in autoinflammatory diseases and cancer
New Targets, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810014 • DOI: 10.18416/CIO.2018.1810014
Views: 709 | Downloads: 348 -
A pan-cancer landscape of interactions between tumors and infiltrating immune cells
New Targets, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810015 • DOI: 10.18416/CIO.2018.1810015
Views: 740 | Downloads: 343 -
Rediscovering an old story: HLA class I alterations and immune escape of tumors in the context of immunotherapies
New Targets, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810029 • DOI: 10.18416/CIO.2018.1810029
Views: 729 | Downloads: 329 -
Biparatopic heavy chain antibodies (bi-hcAbs): fusion of two distinct CD38-specific nanobodies into a human IgG1 bi-hcAb results in potent CDC vs. myeloma cells
New Targets, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810041 • DOI: 10.18416/CIO.2018.1810041
Views: 911 | Downloads: 486 -
Activation of MDA5 improves anti-tumor therapy and reduces suppressive capacity of myeloid-derived suppressor cells
New Targets, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810042 • DOI: 10.18416/CIO.2018.1810042
Views: 840 | Downloads: 352 -
Effect of both PD-1/PD-L1 and ERK inhibitor on Cisplatin-sensitive (HEY) and Cisplatin-resistant (HEY-Cis) ovarian cancer cell lines
New Targets, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810043 • DOI: 10.18416/CIO.2018.1810043
Views: 874 | Downloads: 862 -
Effect of both PD-1/PD-L1 and ERK inhibitor on triple negative breast cancer cell lines and the non-triple negative cell line MCF-7
New Targets, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810044 • DOI: 10.18416/CIO.2018.1810044
Views: 797 | Downloads: 430 -
Regulatory T cells in endogenous mouse lymphoma are antigen-specific nTregs and provide a target for immune checkpoint-inhibiting therapies
New Targets, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810045 • DOI: 10.18416/CIO.2018.1810045
Views: 867 | Downloads: 358 -
Specific targeting of oncogenic mutations using CRISPR-technology to destroy activated oncogenes and enhance immune response
New Targets, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810046 • DOI: 10.18416/CIO.2018.1810046
Views: 738 | Downloads: 957
Microbiome
-
Tumor and host factors regulating anti-tumor immunity and immotherapy efficacy
Microbiome, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810019 • DOI: 10.18416/CIO.2018.1810019
Views: 844 | Downloads: 333
Resistance / Immunosuppression
-
MDSC as a new target for cancer immunotherapy
Resistance / Immunosuppression, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810022 • DOI: 10.18416/CIO.2018.1810022
Views: 730 | Downloads: 339 -
Neo-adjuvant checkpoint inhibition – the pathway towards personalized immunotherapy
Resistance / Immunosuppression, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810023 • DOI: 10.18416/CIO.2018.1810023
Views: 799 | Downloads: 335 -
Interference between tumor mutational burden, HPV status, immune signatures and outcome in patients with head and neck cancer treated with chemoradiotherapy: Results from a multicenter retrospective study of the German Cancer Consortium Radiation Oncology
Resistance / Immunosuppression, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810024 • DOI: 10.18416/CIO.2018.1810024
Views: 777 | Downloads: 366
Combinational Strategies
-
Dynamics of conversation: Immunotherapy meets tumor microenvironment
Combinational Strategies, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810025 • DOI: 10.18416/CIO.2018.1810025
Views: 712 | Downloads: 312 -
Modulating the tumor microenvironment
Combinational Strategies, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810027 • DOI: 10.18416/CIO.2018.1810027
Views: 653 | Downloads: 284
Immunomodulation / Tumor Biology
-
Integrin ?4 synergizes with E-and P-selectin to regulate tumor growth: Unravelling the molecular mechanisms
Immunomodulation / Tumor Biology, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810033 • DOI: 10.18416/CIO.2018.1810033
Views: 894 | Downloads: 336 -
Primary and recurrent head and neck squamous carcinomas are strikingly different regarding their immune microenvironment
Immunomodulation / Tumor Biology, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810035 • DOI: 10.18416/CIO.2018.1810035
Views: 979 | Downloads: 299 -
The role of NFATc1 in T cell-mediated immune responses during the development of lung cancer
Immunomodulation / Tumor Biology, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810036 • DOI: 10.18416/CIO.2018.1810036
Views: 942 | Downloads: 317 -
Role of glycolysis for intestinal inflammation and carcinogenesis
Immunomodulation / Tumor Biology, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810037 • DOI: 10.18416/CIO.2018.1810037
Views: 779 | Downloads: 397 -
MALDI-imaging: Identification of protein signatures of genomic instability in colorectal cancers
Immunomodulation / Tumor Biology, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810039 • DOI: 10.18416/CIO.2018.1810039
Views: 755 | Downloads: 328 -
Investigating a potential role of Got1 in T cell exhaustion.
Immunomodulation / Tumor Biology, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810040 • DOI: 10.18416/CIO.2018.1810040
Views: 900 | Downloads: 388
Therapy Prognosis / Prediction
-
Effects of EGFR-MEK-ERK pathway on PD-L1 expression in head and neck squamous cell carcinoma
Therapy Prognosis / Prediction, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810047 • DOI: 10.18416/CIO.2018.1810047
Views: 1117 | Downloads: 353 -
The emerging role of extracellular vesicles in clinical research inflammation, cancer progression, metastasis
Therapy Prognosis / Prediction, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810048 • DOI: 10.18416/CIO.2018.1810048
Views: 748 | Downloads: 361 -
CD8+ T cell response to HPV16 E7 predicts survival outcome in oropharyngeal cancer
Therapy Prognosis / Prediction, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810050 • DOI: 10.18416/CIO.2018.1810050
Views: 716 | Downloads: 322
Therapeutic Strategies / Approaches
-
Current status of radiotherapy/radiochemotherapy and immunotherapy combinations– a German survey
Therapeutic Strategies / Approaches, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810051 • DOI: 10.18416/CIO.2018.1810051
Views: 740 | Downloads: 361 -
Activation of immune response in refractory patients to standard treatment (T.R.A.N.S.L.A.T.E.)
Therapeutic Strategies / Approaches, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810052 • DOI: 10.18416/CIO.2018.1810052
Views: 749 | Downloads: 326 -
Which adjuvants for tumor-antigen vaccination induce powerful non-sialylated IgG antibodies?
Therapeutic Strategies / Approaches, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810053 • DOI: 10.18416/CIO.2018.1810053
Views: 684 | Downloads: 309 -
Killing melanoma cells with ROS provides immuno-protection against tumor growth in vivo
Therapeutic Strategies / Approaches, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810055 • DOI: 10.18416/CIO.2018.1810055
Views: 770 | Downloads: 392 -
Pre- and intratherapeutic cellular monitoring for dose adjustment of chemotherapy in aggressive lymphoma
Therapeutic Strategies / Approaches, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810056 • DOI: 10.18416/CIO.2018.1810056
Views: 804 | Downloads: 327 -
Combining anti-VEGF-A and anti-PD-L1 therapy prolongs overall survival in small cell lung carcinomas
Therapeutic Strategies / Approaches, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810057 • DOI: 10.18416/CIO.2018.1810057
Views: 1142 | Downloads: 358 -
Robust GMP manufacturing process with IL-2 and a glycoprotein antibody cocktail generates highly active human NK cell batches for cancer immunotherapy
Therapeutic Strategies / Approaches, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810058 • DOI: 10.18416/CIO.2018.1810058
Views: 1053 | Downloads: 312 -
Progression of head and neck cancer is associated with elevated neutrophil extracellular traps formation by circulating neutrophils
Therapeutic Strategies / Approaches, Proceedings on Cancer-Immuno-Oncology, Vol 1, No 1, 2018 • Article ID: 1810059 • DOI: 10.18416/CIO.2018.1810059
Views: 833 | Downloads: 390